Nextech Invest

Nextech Invest is a venture capital and private equity firm specializing in early, mid-stage, late-stage, and emerging growth.

Business Model:

Revenue: $5.3M

Employees: 2-10

Rankings

Detailed Nextech Invest Information

Geographic Data

Nextech Invest headquarters map

Address: Scheuchzerstrasse 35

City: Zurich

State: other

Zip: 8006

Country: CH

Financial Info

Stage:

Raised Last:

$0

Raised Total:

$124M

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

Nextech Invest is a venture capital and private equity firm specializing in early, mid-stage, late-stage, and emerging growth investments. The firm also invests in incorporation, spin-outs, reverse-take-over, and PIPE transactions. It only considers investments where evidence in preclinical animal models that a drug is efficacious is available or a device prototype fulfills the requirements. The firm seeks to invest in the field of information technology, biotechnology, and healthcare with a focus on oncology companies developing cancer drugs and diagnostics. It prefers to invest in life science and enabling technologies with a focus on interdisciplinary technical and scientific projects, therapies, diagnostics, medical technologies, and services. The firm seeks to invest in companies based in Africa, the Middle East, Asia, North America, and Europe including Switzerland, Germany, and neighboring regions. It also considers co-investments in the rest of Europe. The firm seeks to invest between CHF 1 million ($0.93 million) and CHF 5 million ($4.7 million) per financing round. It seeks a Board position in the portfolio companies. The firm seeks to exit its investments within three years via trade sale. Nextech Invest Ltd. was founded in 1998 and is based in Zurich, Switzerland.

Contact Phone:

Contact Email:

Announced Date Company Transaction Money Raised
9/2017 Autolus Series C 80M
9/2017 ImaginAb Venture Round 0
3/2020 Circle Pharma Series B 0
11/2019 PMV Pharmaceuticals Series C 0
3/2020 Silverback Therapeutics Series B 0
9/2016 Peloton Therapeutics Series D 0
1/2021 Scorpion Therapeutics Series B 162M
4/2021 Theseus Pharmaceuticals Series B 0
12/2019 Kinnate Biopharma Series B 74.5M
1/2022 Alterome Therapeutics Series A 0
11/2014 Blueprint Medicines Series C 50M
3/2021 Tyra Biosciences Series B 106M
4/2021 Boundless Bio Series B 105M
4/2018 Revolution Medicines Series B 56M
9/2021 Hexagon Bio Series B 61M
4/2019 Vividion Therapeutics Series B 82M
4/2020 MOMA Therapeutics Series A 86M
10/2018 Turning Point Therapeutics Equity 80M
5/2023 Boundless Bio Series C 0
12/2022 Alpha9 Theranostics Series B 0
11/2022 Alterome Therapeutics Series A 0
10/2022 Hexagon Bio Series B 0
8/2022 Idrx Series A 0
10/2021 Exo Therapeutics Series B 0
3/2023 Flare Therapeutics Series B 0
5/2011 TetraLogic Pharmaceuticals Series C 6M
7/2005 Ganymed Pharmaceuticals Series B 14.4M
5/2014 ImaginAb Series B 21M
12/2017 Neon Therapeutics Series B 36M
6/2020 C4 Therapeutics Series B 150M
4/2011 TRACON Pharmaceuticals Series A 14M
7/2019 Revolution Medicines Series C 100M
3/2018 IDEAYA Biosciences Series B 0
7/2007 Agensys Series D 41.3M
3/2015 Kura Oncology Private Equity Round 60M
6/2002 Ganymed Pharmaceuticals Series A 8.3M
9/2008 Telormedix Series A 0
4/2015 Jounce Therapeutics Series B 0
1/2021 EQRx Series B 500M
8/2016 Cleave Therapeutics Series B 0
2/2021 Vividion Therapeutics Series C 135M
10/2020 A2 Biotherapeutics Series B 71.5M
9/2014 TRACON Pharmaceuticals Series B 0
1/2022 AmbAgon Therapeutics Series A 0
12/2019 Black Diamond Therapeutics Series C 0
3/2023 CARGO Therapeutics Series A 0
1/2019 Black Diamond Therapeutics Series B 85M
1/2017 Neon Therapeutics Series B 70M
1/2014 Blueprint Medicines Series B 25M
8/2020 PMV Pharmaceuticals Series D 70M
5/2021 Flare Therapeutics Series A 82M
4/2009 Sunesis Pharmaceuticals Post-IPO Equity 0
12/2020 Cullinan Oncology Series C 131.2M
1/2021 IconOVir Bio Series A 0
7/2019 Kronos Bio Series A 105M
4/2012 MolecularMD Series B 6M
6/2023 K36 Therapeutics Series B 0
6/2023 ORIC Pharmaceuticals Post-IPO Equity 0
6/2023 Isotopen Technologien München Private Equity Round 0
11/2019 A2 Biotherapeutics Series A 57M
2/2019 Peloton Therapeutics Series E 0
1/2020 EQRx Series A 200M
9/2020 Silverback Therapeutics Series C 85M
6/2021 Circle Pharma Series C 0
8/2021 Atavistik Bio Series A 60M
5/2022 MOMA Therapeutics Series B 0
4/2019 Arrakis Therapeutics Series B 75M
4/2018 Arvinas Series C 55M
8/2020 Kronos Bio Private Equity Round 155M
8/2020 Kinnate Biopharma Series C 98M
6/2023 K36 Therapeutics Series B 0
6/2023 ORIC Pharmaceuticals Post-IPO Equity 0
6/2023 Isotopen Technologien München Private Equity Round 0
5/2023 Boundless Bio Series C 0
3/2023 Flare Therapeutics Series B 0
3/2023 CARGO Therapeutics Series A 0
12/2022 Alpha9 Theranostics Series B 0
11/2022 Alterome Therapeutics Series A 0
10/2022 Hexagon Bio Series B 0
8/2022 Idrx Series A 0

Startup Industries

Startup Locations

Portfolio Current Status

Portfolio Employee Count

Name Price
Name Size Announced Date

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research